A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

December 31, 2006

Conditions

Type 1 Diabetes

Interventions

DRUG

E1 and G1

Trial Locations (5)

Diabetes - Endocrinology Center of West New York, Buffalo

Highgate Specialty Center, Durham

Pinnacle Research Group, Anniston

Diablo Clinical Research, Walnut Creek

Diabetes and Glandular Disease Research Associates, San Antonio

All Listed Sponsors

lead

OPKO Health, Inc.

INDUSTRY

NCT00239148 - A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1 | Biotech Hunter | Biotech Hunter